Drug Addiction Clinical Trial
Official title:
Four Models of Telephone Support for Stimulant Recovery
Verified date | November 2016 |
Source | University of California, Los Angeles |
Contact | n/a |
Is FDA regulated | No |
Health authority | United States: Federal Government |
Study type | Interventional |
The overall objective of this research is to develop and refine empirically supported continuing care interventions that promote healthy behavior and sustained abstinence from illicit drug use.
Status | Completed |
Enrollment | 302 |
Est. completion date | September 2011 |
Est. primary completion date | September 2010 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 18 Years to 65 Years |
Eligibility |
Inclusion Criteria: - Males or females, 18-65 years of age. - Meet DSM-IV criteria (at the time of treatment admission) for cocaine or methamphetamine abuse/dependence. - Have completed the primary phase of treatment at a Matrix outpatient clinic. - Have telephone access throughout the study procedures. - Be able to understand and complete rating scales and to follow instructions. - Be willing to sign an informed consent form. Exclusion Criteria: - Have participated in a treatment-related study conducted by the PI and colleagues during the previous 3 years and/or is currently enrolled in a treatment-related study. - Have any medical, legal, housing or transportation problem which would preclude either safe or consistent participation. - Have dropped out of the primary phase of treatment prior to completion. |
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Supportive Care
Country | Name | City | State |
---|---|---|---|
United States | Twin Town Treatment Center | Los Alamitos | California |
United States | Matrix Institute on Addictions | Los Angeles | California |
United States | UCLA Integrated Substance Abuse Programs | Los Angeles | California |
United States | Matrix Institute on Addictions | Rancho Cucamonga | California |
United States | Twin Town Treatment Center | West Hollywood | California |
United States | Matrix Institute on Addicitions | Woodland Hills | California |
Lead Sponsor | Collaborator |
---|---|
University of California, Los Angeles | National Institute on Drug Abuse (NIDA) |
United States,
Ahles TA, Schlundt DG, Prue DM, Rychtarik RG. Impact of aftercare arrangements on the maintenance of treatment success in abusive drinkers. Addict Behav. 1983;8(1):53-8. — View Citation
Allen K. Barriers to treatment for addicted African-American women. J Natl Med Assoc. 1995 Oct;87(10):751-6. — View Citation
Ashery RS, Carlson RG, Falck RS, Siegal HA. Injection drug users, crack-cocaine users, and human services utilization: an exploratory study. Soc Work. 1995 Jan;40(1):75-82. — View Citation
Baron RM, Kenny DA. The moderator-mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations. J Pers Soc Psychol. 1986 Dec;51(6):1173-82. — View Citation
Battjes RJ, Onken LS, Delany PJ. Drug abuse treatment entry and engagement: report of a meeting on treatment readiness. J Clin Psychol. 1999 May;55(5):643-57. — View Citation
Brown BS, O'Grady KE, Battjes RJ, Farrell EE, Smith NP, Nurco DN. Effectiveness of a stand-alone aftercare program for drug-involved offenders. J Subst Abuse Treat. 2001 Dec;21(4):185-92. — View Citation
Burton P, Gurrin L, Sly P. Extending the simple linear regression model to account for correlated responses: an introduction to generalized estimating equations and multi-level mixed modelling. Stat Med. 1998 Jun 15;17(11):1261-91. — View Citation
De Leon G, Melnick G, Kressel D, Jainchill N. Circumstances, motivation, readiness, and suitability (the CMRS scales): predicting retention in therapeutic community treatment. Am J Drug Alcohol Abuse. 1994 Nov;20(4):495-515. — View Citation
De Leon G, Melnick G, Thomas G, Kressel D, Wexler HK. Motivation for treatment in a prison-based therapeutic community. Am J Drug Alcohol Abuse. 2000 Feb;26(1):33-46. — View Citation
Dees SM, Dansereau DF, Peel JL, Boatler JG, Knight K. Using conceptual matrices, knowledge maps, and scripted cooperation to improve personal management strategies. J Drug Educ. 1991;21(3):211-30. — View Citation
Diez-Roux AV. Multilevel analysis in public health research. Annu Rev Public Health. 2000;21:171-92. Review. — View Citation
Farabee D, Cousins SJ, Brecht ML, Antonini VP, Lee AB, Brummer J, Hemberg J, Karno M, Rawson RA. A comparison of four telephone-based counseling styles for recovering stimulant users. Psychol Addict Behav. 2013 Mar;27(1):223-9. doi: 10.1037/a0029572. — View Citation
Farabee D, Rawson R, McCann M. Adoption of drug avoidance activities among patients in contingency management and cognitive-behavioral treatments. J Subst Abuse Treat. 2002 Dec;23(4):343-50. — View Citation
Fischer B, Chin AT, Kuo I, Kirst M, Vlahov D. Canadian illicit opiate users' views on methadone and other opiate prescription treatment: an exploratory qualitative study. Subst Use Misuse. 2002 Mar;37(4):495-522. — View Citation
Fitzgerald JL, Mulford HA. An experimental test of telephone aftercare contacts with alcoholics. J Stud Alcohol. 1985 Sep;46(5):418-24. — View Citation
Fortney JC, Booth BM, Blow FC, Bunn JY. The effects of travel barriers and age on the utilization of alcoholism treatment aftercare. Am J Drug Alcohol Abuse. 1995 Aug;21(3):391-406. — View Citation
Haynes RB, McDonald HP, Garg AX. Helping patients follow prescribed treatment: clinical applications. JAMA. 2002 Dec 11;288(22):2880-3. — View Citation
Hser YI, Anglin D, Powers K. A 24-year follow-up of California narcotics addicts. Arch Gen Psychiatry. 1993 Jul;50(7):577-84. — View Citation
Hser YI, Hoffman V, Grella CE, Anglin MD. A 33-year follow-up of narcotics addicts. Arch Gen Psychiatry. 2001 May;58(5):503-8. — View Citation
Huber A, Ling W, Shoptaw S, Gulati V, Brethen P, Rawson R. Integrating treatments for methamphetamine abuse: a psychosocial perspective. J Addict Dis. 1997;16(4):41-50. — View Citation
Huber A, Lord RH, Gulati V, Marinelli-Casey P, Rawson R, Ling W. The CSAT methamphetamine treatment program: research design accommodations for "real world" application. J Psychoactive Drugs. 2000 Apr-Jun;32(2):149-56. — View Citation
Hunt WA, Barnett LW, Branch LG. Relapse rates in addiction programs. J Clin Psychol. 1971 Oct;27(4):455-6. — View Citation
Iguchi MY, Belding MA, Morral AR, Lamb RJ, Husband SD. Reinforcing operants other than abstinence in drug abuse treatment: an effective alternative for reducing drug use. J Consult Clin Psychol. 1997 Jun;65(3):421-8. — View Citation
Intagliata J. A telephone follow-up procedure for increasing the effectiveness of a treatment program for alcoholics. J Stud Alcohol. 1976 Sep;37(9):1330-5. — View Citation
Karno MP, Beutler LE, Harwood TM. Interactions between psychotherapy procedures and patient attributes that predict alcohol treatment effectiveness: a preliminary report. Addict Behav. 2002 Sep-Oct;27(5):779-97. — View Citation
Koumans AJ, Muller JJ, Miller CF. Use of telephone calls to increase motivation for treatment in alcoholics. Psychol Rep. 1967 Aug;21(1):327-8. — View Citation
Lash SJ, Blosser SL. Increasing adherence to substance abuse aftercare group therapy. J Subst Abuse Treat. 1999 Jan;16(1):55-60. — View Citation
Lash SJ, Dillard W. Encouraging participation in aftercare group therapy among substance-dependent men. Psychol Rep. 1996 Oct;79(2):585-6. — View Citation
Lovejoy M, Rosenblum A, Magura S, Foote J, Handelsman L, Stimmel B. Patients' perspective on the process of change in substance abuse treatment. J Subst Abuse Treat. 1995 Jul-Aug;12(4):269-82. — View Citation
MacKinnon DP, Lockwood CM, Hoffman JM, West SG, Sheets V. A comparison of methods to test mediation and other intervening variable effects. Psychol Methods. 2002 Mar;7(1):83-104. — View Citation
McDonald HP, Garg AX, Haynes RB. Interventions to enhance patient adherence to medication prescriptions: scientific review. JAMA. 2002 Dec 11;288(22):2868-79. Review. Erratum in: JAMA. 2003 Jun 25;289(24):3242. — View Citation
McKay JR, McLellan AT, Alterman AI, Cacciola JS, Rutherford MJ, O'Brien CP. Predictors of participation in aftercare sessions and self-help groups following completion of intensive outpatient treatment for substance abuse. J Stud Alcohol. 1998 Mar;59(2):152-62. — View Citation
McKay JR. Effectiveness of continuing care interventions for substance abusers. Implications for the study of long-term treatment effects. Eval Rev. 2001 Apr;25(2):211-32. Review. — View Citation
Ouimette PC, Moos RH, Finney JW. Influence of outpatient treatment and 12-step group involvement on one-year substance abuse treatment outcomes. J Stud Alcohol. 1998 Sep;59(5):513-22. — View Citation
Pan W. Sample size and power calculations with correlated binary data. Control Clin Trials. 2001 Jun;22(3):211-27. — View Citation
Peterson KA, Swindle RW, Phibbs CS, Recine B, Moos RH. Determinants of readmission following inpatient substance abuse treatment: a national study of VA programs. Med Care. 1994 Jun;32(6):535-50. — View Citation
Rawson RA, Marinelli-Casey P, Anglin MD, Dickow A, Frazier Y, Gallagher C, Galloway GP, Herrell J, Huber A, McCann MJ, Obert J, Pennell S, Reiber C, Vandersloot D, Zweben J; Methamphetamine Treatment Project Corporate Authors.. A multi-site comparison of psychosocial approaches for the treatment of methamphetamine dependence. Addiction. 2004 Jun;99(6):708-17. — View Citation
Rawson RA, Obert JL, McCann MJ, Ling W. Neurobehavioral treatment for cocaine dependency: a preliminary evaluation. NIDA Res Monogr. 1993;135:92-115. Review. — View Citation
Rawson RA, Shoptaw SJ, Obert JL, McCann MJ, Hasson AL, Marinelli-Casey PJ, Brethen PR, Ling W. An intensive outpatient approach for cocaine abuse treatment. The Matrix model. J Subst Abuse Treat. 1995 Mar-Apr;12(2):117-27. — View Citation
Richter KP, Bammer G. A hierarchy of strategies heroin-using mothers employ to reduce harm to their children. J Subst Abuse Treat. 2000 Dec;19(4):403-13. — View Citation
Rochon J. Application of GEE procedures for sample size calculations in repeated measures experiments. Stat Med. 1998 Jul 30;17(14):1643-58. — View Citation
Shoptaw S, Rawson RA, McCann MJ, Obert JL. The Matrix model of outpatient stimulant abuse treatment: evidence of efficacy. J Addict Dis. 1994;13(4):129-41. — View Citation
Shrout PE, Bolger N. Mediation in experimental and nonexperimental studies: new procedures and recommendations. Psychol Methods. 2002 Dec;7(4):422-45. — View Citation
Silverman K, Higgins ST, Brooner RK, Montoya ID, Cone EJ, Schuster CR, Preston KL. Sustained cocaine abstinence in methadone maintenance patients through voucher-based reinforcement therapy. Arch Gen Psychiatry. 1996 May;53(5):409-15. — View Citation
Sobell LC, Maisto SA, Sobell MB, Cooper AM. Reliability of alcohol abusers' self-reports of drinking behavior. Behav Res Ther. 1979;17(2):157-60. — View Citation
Spitzer RL, Williams JB, Gibbon M, First MB. The Structured Clinical Interview for DSM-III-R (SCID). I: History, rationale, and description. Arch Gen Psychiatry. 1992 Aug;49(8):624-9. — View Citation
Stahler GJ, Cohen E. Using ethnographic methodology in substance abuse treatment outcome research. J Subst Abuse Treat. 2000 Jan;18(1):1-8. — View Citation
Stout RL, Wirtz PW, Carbonari JP, Del Boca FK. Ensuring balanced distribution of prognostic factors in treatment outcome research. J Stud Alcohol Suppl. 1994 Dec;12:70-5. — View Citation
* Note: There are 48 references in all — Click here to view all references
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Urinalyses | At 3 months and 12 months | No | |
Primary | Breathalyzer tests | At 3 months and 12 months | No | |
Primary | Self-report of drug or alcohol use | At 3 months and 12 months | No | |
Primary | Amount of Treatment Activities | At 3 months and 12 months | No | |
Primary | Length of Treatment Episode | At 3 months and 12 months | No | |
Secondary | Addiction Severity Index (ASI) | At 3 months and 12 months | No | |
Secondary | HIV Risk-taking Behavior Scale | At 3 months and 12 months | No | |
Secondary | Concurrent Psychosocial Treatments | At 3 months and 12 months | No | |
Secondary | Drug Avoidance Activities (DAA) Survey | At 3 months and 12 months | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02192931 -
A Randomized Double-Blind Controlled Trial of Creatine in Female Methamphetamine Users
|
Phase 4 | |
Completed |
NCT02437123 -
The Cedar Project: Impact of mHealth for HIV Prevention Among Young Indigenous People Who Use Illicit Drugs
|
N/A | |
Completed |
NCT02282306 -
Phone Interview to Prevent Recurring Opioid Overdoses
|
N/A | |
Completed |
NCT02939352 -
The Effects of Theta Burst Stimulation on the Brain Response to Drug and Alcohol Cues
|
Early Phase 1 | |
Completed |
NCT02224508 -
Evaluation of a Health Plan Initiative to Mitigate Chronic Opioid Therapy Risks
|
N/A | |
Completed |
NCT01685073 -
The Role of Sleep in the Treatment of Cannabis Use Disorders
|
Phase 2/Phase 3 | |
Completed |
NCT01591239 -
Home-Based Program to Help Parents of Drug Abusing Adolescents
|
N/A | |
Completed |
NCT00317460 -
Buprenorphine and Integrated HIV Care
|
Phase 4 | |
Completed |
NCT03678051 -
CBT4CBT for Women in Residential Treatment for Substance Use Disorders
|
N/A | |
Completed |
NCT04105621 -
Westlake Personalized Nutrition and Health Cohort for Drug Addicts
|
||
Withdrawn |
NCT05440721 -
Clinical Trial of an Innovative Digital Therapeutic for Smoking Cessation With Biochemical Verification
|
N/A | |
Completed |
NCT03694327 -
Innovative Digital Therapeutic for Smoking Cessation
|
N/A | |
Completed |
NCT00496990 -
Treating the Partners of Drug Using Pregnant Women: Stage II
|
Phase 2/Phase 3 | |
Completed |
NCT00390559 -
Examining the Effect of the Nicotine Patch in Male and Female Smokers - 3
|
N/A | |
Completed |
NCT00244699 -
Integrating Mindfulness-Based Skills Training Into Brief Outpatient Treatment for Substance Abusing Youth
|
N/A | |
Completed |
NCT03402672 -
AWAITS: A Web-based E-health Application for Active Illicit Opioid Users
|
N/A | |
Completed |
NCT03411265 -
RETAIN: Retaining Opioid Users Entering Medication Assisted Treatment and Encouraging HCV/HIV Testing
|
N/A | |
Completed |
NCT01003496 -
Comparing Acute and Continuous Drug Abuse Treatment: A Randomized Clinical Trial
|
Phase 3 | |
Completed |
NCT02091284 -
Bilateral Prefrontal Modulation in Alcoholism
|
N/A | |
Completed |
NCT02091167 -
Bilateral Prefrontal Modulation in Crack-cocaine Addiction
|
Phase 2 |